FR2205333A1 - 6-Phenanthridone-3-carboxylic or-acetic acids - useful as gastric sec-retion inhibitors and anti-ulcer agents - Google Patents

6-Phenanthridone-3-carboxylic or-acetic acids - useful as gastric sec-retion inhibitors and anti-ulcer agents

Info

Publication number
FR2205333A1
FR2205333A1 FR7339363A FR7339363A FR2205333A1 FR 2205333 A1 FR2205333 A1 FR 2205333A1 FR 7339363 A FR7339363 A FR 7339363A FR 7339363 A FR7339363 A FR 7339363A FR 2205333 A1 FR2205333 A1 FR 2205333A1
Authority
FR
France
Prior art keywords
phenanthridone
retion
gastric
inhibitors
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7339363A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio Guidotti SpA
Original Assignee
Laboratorio Guidotti SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Guidotti SpA filed Critical Laboratorio Guidotti SpA
Publication of FR2205333A1 publication Critical patent/FR2205333A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/10Aza-phenanthrenes
    • C07D221/12Phenanthridines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7339363A 1972-11-06 1973-11-06 6-Phenanthridone-3-carboxylic or-acetic acids - useful as gastric sec-retion inhibitors and anti-ulcer agents Withdrawn FR2205333A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT3131972 1972-11-06

Publications (1)

Publication Number Publication Date
FR2205333A1 true FR2205333A1 (en) 1974-05-31

Family

ID=11233456

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7339363A Withdrawn FR2205333A1 (en) 1972-11-06 1973-11-06 6-Phenanthridone-3-carboxylic or-acetic acids - useful as gastric sec-retion inhibitors and anti-ulcer agents

Country Status (7)

Country Link
JP (1) JPS49133376A (enrdf_load_html_response)
BE (1) BE806984A (enrdf_load_html_response)
DE (1) DE2355084A1 (enrdf_load_html_response)
FR (1) FR2205333A1 (enrdf_load_html_response)
IL (1) IL44001A0 (enrdf_load_html_response)
NL (1) NL7315191A (enrdf_load_html_response)
ZA (1) ZA738479B (enrdf_load_html_response)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011624A1 (en) * 1997-09-03 1999-03-11 Guilford Pharmaceuticals Inc. Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
US6306889B1 (en) 1997-09-03 2001-10-23 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6348475B1 (en) 2000-06-01 2002-02-19 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout
US6380211B1 (en) 1997-09-03 2002-04-30 Guilford Pharmaceutical Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6716828B1 (en) 1999-09-01 2004-04-06 Guilford Pharmaceuticals, Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6723733B2 (en) 2000-05-19 2004-04-20 Guilford Pharmaceuticals, Inc. Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0089426B1 (en) * 1979-07-12 1986-06-11 A.H. Robins Company, Incorporated 2-amino-6-biphenylacetic acids
CA2546657C (en) * 2003-12-05 2013-05-14 Janssen Pharmaceutica N.V. 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
EP2061765B1 (en) * 2006-09-01 2014-10-22 Senhwa Biosciences, Inc. Serine-threonine protein kinase and PARP modulators

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6306889B1 (en) 1997-09-03 2001-10-23 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6380211B1 (en) 1997-09-03 2002-04-30 Guilford Pharmaceutical Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
WO1999011624A1 (en) * 1997-09-03 1999-03-11 Guilford Pharmaceuticals Inc. Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
US6716828B1 (en) 1999-09-01 2004-04-06 Guilford Pharmaceuticals, Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US7307080B2 (en) 1999-09-01 2007-12-11 Mgi Gp, Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6723733B2 (en) 2000-05-19 2004-04-20 Guilford Pharmaceuticals, Inc. Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses
US6348475B1 (en) 2000-06-01 2002-02-19 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout

Also Published As

Publication number Publication date
ZA738479B (en) 1974-11-27
NL7315191A (enrdf_load_html_response) 1974-05-08
IL44001A0 (en) 1974-05-16
JPS49133376A (enrdf_load_html_response) 1974-12-21
BE806984A (fr) 1974-03-01
DE2355084A1 (de) 1974-05-16

Similar Documents

Publication Publication Date Title
FR2205333A1 (en) 6-Phenanthridone-3-carboxylic or-acetic acids - useful as gastric sec-retion inhibitors and anti-ulcer agents
IT1057859B (it) Perivato del triamoinolone
IE38150L (en) Desacetoxycephalosporins and intermediates
ES380932A1 (es) Un procedimiento para la preparacion de acidos 2 - aril-5- -hidroxi-4-pirimidincarbolxilicos.
IE34481B1 (en) 3-acyl-ypsilon-resorcylic acid anilides and process for their manufacture
FR2160246A1 (en) Tannin/methylcellulose compsns - dermatological antiseptics
FR2054955A5 (en) Antimicrobial n-subst 6,7-methylenedioxy-4- - quinolone derivs prepn
NL7010194A (en) Antimicrobial n-subst 6,7-methylenedioxy-4- - quinolone derivs prepn
BE753153A (en) Antimicrobial n-subst 6,7-methylenedioxy-4- - quinolone derivs prepn
GB1296655A (enrdf_load_html_response)
JPS53126063A (en) Production of chitin derivative
ES408183A1 (es) Procedimiento para la preparacion de la pinicilamina o de sus homologos.
FR2160719A1 (en) Benzimidazolyl propanol derivs - respiratory analeptics spasmolytics analgesics antiinflammatories vasodilators and hypotensi
FR2198735A1 (en) Substd 3-alkyl 2-nitrobenzofurans - by nitration of corresp 2-acyl derivs, used as parasiticides
FR2154326A1 (en) (7' or 8' chloro-4-quinolinyl)-2-amino-nicotinic acid derivs - - analgesic,antiinflammatory
ES481296A1 (es) Un procedimiento para la preparacion de esteres de deriva- dos del acido aminolo-piran-4-ona-2-carboxilico.
FR2152377A1 (en) 1-phenyl-2-methyl-5-alkyl or alkoxy-3-indolylacetic acid - derivs - antiinflammatory, analgesic, antipyretic
ES420666A1 (es) Procedimiento para preparar derivados de acidos (1-metil-5-nitro-2-imidazolil)tioalcanoicos.
FR2134121A1 (en) Piperazino ethyl phloroglucates prepn - useful as vasodilators
BE784666A (en) Benzopyran derivs - inters in total steroid synthesis
FR2101148A1 (en) Spiroheterocycloalkane phenyl acetic acid derivs - antiinflammatores and analgesics
BE805111A (en) 13,14-Dihydroprostaglandins - resistant to enzymatic deactivation, useful as muscle contractants, hypotensives etc
ES405081A1 (es) Procedimiento para la obtencion de dibenzo (d,f) dioxepinas-(1,3).
FR2191894A1 (en) Vincamine and apovincaminic esters and N-oxides - cerebrovascular agents prepd by transesterification of methyl esters and opt oxidn
FR2238485A1 (en) Anti-inflammatory and analgesic glyceryl esters - of substd 4-phenyl-butyric and 4-phenyl-4-oxobutyric acids

Legal Events

Date Code Title Description
ST Notification of lapse